Morgan Stanley analyst Dara Mohsenian lowered the firm’s price target on Olaplex (OLPX) to $1.40 from $1.75 and keeps an Equal Weight rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLPX:
- Olaplex price target lowered to $1.25 from $1.50 at Barclays
- Olaplex Holdings: Hold Rating Amid Turnaround Progress and Competitive Challenges
- Olaplex Earnings Call: Mixed Sentiment Amid Challenges
- Olaplex Holdings: Strong Q3 Performance and Strategic Innovations Support Buy Rating
- Olaplex Holdings Reports Mixed Q3 2025 Results